HLB Co., Ltd. (KOSDAQ:028300)

Market Cap	5.48T
Revenue (ttm)	74.64B
Net Income (ttm)	-188.47B
Shares Out	131.18M
EPS (ttm)	-1,440.96
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	418,881
Average Volume	568,161
Open	41,900
Previous Close	41,750
Day's Range	40,400 - 42,350
52-Week Range	39,700 - 97,600
Beta	0.24
RSI	27.68
Earnings Date	Aug 12, 2025

About Silk Road Medical

HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. HLB Co., Ltd. was founded in...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1975
• Employees: 160
• Stock Exchange: KOSDAQ
• Ticker Symbol: 028300

Financial Performance

In 2024, HLB Co., Ltd.'s revenue was 68.13 billion, an increase of 58.80% compared to the previous year's 42.90 billion. Losses were -91.98 billion, -50.96% less than in 2023.